Encompass Health reports results for fourth quarter 2017 and reiterates full-year 2018 guidance
Go back to Encompass Health reports results for fourth quarter 2017 and reiterates full-year 2018 guidance| 11% CELGENE CORP. ELKS DUE APRIL 06, 2009 (NYSE: EHC) | Delayed: 98.94 +0.91 (0.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $98.03 | 52 Week High | $11.60 | |||
| Open | $97.82 | 52 Week Low | $4.00 | |||
| Day High | $99.53 | P/E | N/A | |||
| Day Low | $97.19 | EPS | $0.00 | |||
| Volume | 537,184 | |||||
